March Altus Capital Management LP - ENZYMOTEC LTD ownership

ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 23 filers reported holding ENZYMOTEC LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
March Altus Capital Management LP ownership history of ENZYMOTEC LTD
ValueSharesWeighting
Q4 2014$5,127,000
+12.6%
681,7780.0%2.34%
+29.2%
Q3 2014$4,554,000
+397.7%
681,778
+910.6%
1.81%
+440.9%
Q2 2014$915,000
-87.3%
67,463
-79.4%
0.34%
-85.6%
Q1 2014$7,222,000
+31.7%
327,962
+61.6%
2.32%
+39.7%
Q4 2013$5,482,000202,9621.66%
Other shareholders
ENZYMOTEC LTD shareholders Q4 2013
NameSharesValueWeighting ↓
TIGER MANAGEMENT L.L.C. 804,854$7,284,0000.97%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 96,600$874,0000.33%
Visium Asset Management, LP 2,200,000$19,910,0000.27%
Paulson & Co. 4,238,275$38,356,0000.20%
Rotella Capital Management, Inc. 17,118$155,0000.05%
MENTA CAPITAL LLC 15,870$144,0000.02%
Renaissance Technologies 146,000$1,321,0000.00%
MILLENNIUM MANAGEMENT LLC 147,144$1,332,0000.00%
ACADIAN ASSET MANAGEMENT LLC 51,370$464,0000.00%
GOLDMAN SACHS GROUP INC 947,723$8,577,0000.00%
View complete list of ENZYMOTEC LTD shareholders